The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peritoneum metastasis (PM) as a prognostic factor in metastatic gastric cancer (MGC) treated with anti-PD-1/PD-L1 monotherapy.
 
Yukiya Narita
Honoraria - Chugai Pharma; Lilly; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Chugai Pharma; Lilly; Taiho Pharmaceutical; Takeda
Research Funding - Takeda (Inst)
 
Keiji Sugiyama
No Relationships to Disclose
 
Seiichiro Mitani
No Relationships to Disclose
 
Kazunori Honda
No Relationships to Disclose
 
Toshiki Masuishi
No Relationships to Disclose
 
Hiroya Taniguchi
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Boehringer Ingelheim (Inst); MSD Oncology (Inst); Otsuka (Inst); Takeda (Inst)
 
Shigenori Kadowaki
Honoraria - Chugai Pharma; Lilly; Merck
 
Takashi Ura
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Merck; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Ono Pharmaceutical
 
Masashi Ando
Consulting or Advisory Role - Novartis
Speakers' Bureau - Eisai; Novartis
 
Masahiro Tajika
Speakers' Bureau - Ajinomoto
Research Funding - Ajinomoto (Inst)
 
Kei Muro
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha